Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Archaea for Human Health

Project description

Harnessing the power of the smallest to transform healthcare

In the world of the human microbiome, Archaea (the ‘third domain of life’) remain largely uncharted territory. Beside bacteria and fungi, Archaea have been described as a stable component of the human microbiome. The ERC-funded ArcHealth project seeks to expand the related narrative. With only a few Archaea isolated from humans to date, ArcHealth aims to harness these elusive microorganisms. Their breakthrough achievement is the cultivation of Archaea for medical use. This groundbreaking research promises a paradigm shift in treatment standards, offering sustainable, safe and beneficial solutions derived from our own bodies. ArcHealth paves the way for a new era of personalised medicine.

Objective

"Beside Bacteria and fungi, Archaea, the ""third domain of life"" have been described as a stable component of the human microbiome. Yet, only few archaea have so far been isolated from humans.
The project aims to demonstrate that a fundamentally new product, derived from archaea, revolutionizing current standards of treatments for human health, can be developed from our initial breakthrough achievement, the cultivation of these archaea. The benefits of using archaea derived from human bodies, promise a sustainable, safe and beneficial treatment in the future."

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-POC

See all projects funded under this call

Host institution

UNIVERSITAT WIEN
Net EU contribution
€ 110 000,00
Address
UNIVERSITATSRING 1
1010 Wien
Austria
Region
Ostösterreich Wien Wien
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (2)